Pathogenic Features of Porphyromonas Gingivalis Influence Progression of Rheumatoid Arthritis

Pathogenic Features of Porphyromonas Gingivalis Influence Progression of Rheumatoid Arthritis

Autoimmune diseases, such as rheumatoid arthritis (RA), are examples of yet not entirely understood etiology. They are linked to immune system dysfunction, which becomes immunologically overactive, damaging the body’s tissues and organs. At least three major factors underlie the development of autoi...

Full description

Bibliographic Details
Main Authors:	Krakowiak Wiktoria, Lisowska Halina, Kaca Wieslaw Roman
Format:	Article
Language:	English
Published:	Sciendo 2024-03-01
Series:	Postępy Mikrobiologii
Subjects:	autoimmune disease citrullination process dysbiosis ppad enzyme rheumatoid arthritis
Online Access:	https://doi.org/10.2478/am-2024-0002

Similar Items

Citrullination as a plausible link to periodontitis, rheumatoid arthritis, atherosclerosis and Alzheimer’s disease
by: Ingar Olsen, et al.
Published: (2018-01-01)

Outer membrane vesicles of the oral pathogen Porphyromonas gingivalis promote aggregation and phagocytosis of Staphylococcus aureus
by: Marines du Teil Espina, et al.
Published: (2022-07-01)

Standardization of enzyme-linked immunosorbent assay to detect anti- Porphyromonas gingivalis-peptidylarginine-deiminase antibodies
by: Juliana Cristina Carlos, et al.
Published: (2018-12-01)

Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives
by: Marta Vomero, et al.
Published: (2018-07-01)

Antibodies against Porphyromonas gingivalis in serum and saliva and their association with rheumatoid arthritis and periodontitis. Data from two rheumatoid arthritis cohorts in Sweden
by: Anna Svärd, et al.
Published: (2023-05-01)

Novel autoantibodies in rheumatoid arthritis
by: A.F. Bonifacio, et al.
Published: (2019-04-01)

The Relationship Between Porphyromonas Gingivalis and Rheumatoid Arthritis: A Meta-Analysis
by: Yilin Li, et al.
Published: (2022-07-01)

There's no place like OM: Vesicular sorting and secretion of the peptidylarginine deiminase of Porphyromonas gingivalis
by: Giorgio Gabarrini, et al.
Published: (2018-12-01)

Host and bacterial factors linking periodontitis and rheumatoid arthritis
by: Anna Krutyhołowa, et al.
Published: (2022-08-01)

Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis
by: Yanli Tong, et al.
Published: (2020-01-01)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
by: Nicole H. Trier, et al.
Published: (2019-06-01)

Rheumatoid factor and antibodies against cyclic citrullinated peptide in patients without rheumatoid arthritis
by: N. V. Bunchuk
Published: (2023-01-01)

Implication of the Association of Fibrinogen Citrullination and Osteoclastogenesis in Bone Destruction in Rheumatoid Arthritis
by: Ji Soo Kim, et al.
Published: (2020-12-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
by: Hui-Chun Yu, et al.
Published: (2019-01-01)

The diagnostic value of the second generation anti-CCP test in rheumatoid arthritis
by: Spasovski Dejan, et al.
Published: (2008-01-01)

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
by: E N Aleksandrova, et al.
Published: (2004-12-01)

Citrullination in Rheumatoid Arthritis—A Process Promoted by Neutrophil Lysis?
by: Tal Gazitt, et al.
Published: (2016-10-01)

Antibodies against citrullinated proteins in relation to periodontitis with or without rheumatoid arthritis: a cross-sectional study
by: Pit Hui Lew, et al.
Published: (2021-07-01)

ACCP-negative rheumatoid arthritis – clinical and immunological features
by: D. A. Dibrov
Published: (2022-07-01)

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
by: Marino Paroli, et al.
Published: (2023-10-01)

Anti-citrullinated Protein Antibody Generation, Pathogenesis, Clinical Application, and Prospects
by: Jiaxi Liu, et al.
Published: (2022-01-01)

Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
by: Refaat M El Tanawy, et al.
Published: (2015-01-01)

Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis
by: Akio Umemoto, et al.
Published: (2023-02-01)

Correlation between anti-mutated citrullinated vimentin and bone turnover markers (CTX-1 and P1NP) in patients with rheumatoid arthritis in remission and low-disease activity
by: Tulus Widiyanto, et al.
Published: (2022-08-01)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
by: Hisakata Yamada, et al.
Published: (2020-04-01)

Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
by: E. L. Nasonov, et al.
Published: (2023-06-01)

The emerging role of neutrophil extracellular traps in the progression of rheumatoid arthritis
by: Jingjing Chen, et al.
Published: (2024-08-01)

The clinical aspect of overweight on rheumatoid arthritis and disease activity
by: Haitham Ahmed, et al.
Published: (2019-06-01)

Collagen Autoantibodies and Their Relationship to CCP Antibodies and Rheumatoid Factor in the Progression of Early Rheumatoid Arthritis
by: Senga F. Whittingham, et al.
Published: (2017-04-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01)

Methotrexate-induced changes in the concentration of antibodies to modified citrulnated vimentin in blood serum of patients with rheumatoid arthritis
by: Natal'ya Petrovna Shilkina, et al.
Published: (2011-05-01)

The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
by: J. Parantainen, et al.
Published: (2022-11-01)

Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort
by: Gaël Mouterde, et al.
Published: (2019-06-01)

Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
by: D. A. Dibrov, et al.
Published: (2023-04-01)

Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
by: Anna-Lena Mueller, et al.
Published: (2021-11-01)

Multicenter, observational clinical study of abatacept in Japanese patients with rheumatoid arthritis
by: Noriyoshi Ogawa, et al.
Published: (2019-01-01)

Dysbiosis, gut-blood barrier rupture and autoimmune response in rheumatoid arthritis and schizophrenia
by: Maria Maślińska, et al.
Published: (2021-07-01)

B cell autoimmunity and bone damage in rheumatoid arthritis
by: S. Bugatti, et al.
Published: (2016-12-01)

EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2018-07-01)

Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis
by: Alessandra Zaccardelli, et al.
Published: (2019-11-01)